Abstract
Aluminum oxide nanoparticles (Al2O3 NPs) are among the most widely used nanomaterials; however, relatively little information about their risk identification and assessment is available. In the present study, we aimed to investigate the potential toxicity of Al2O3 NPs following repeated inhalation exposure in male Sprague-Dawley rats. Rats were exposed to Al2O3 NPs for 28 days (5 days/week) at doses of 0, 0.2, 1, and 5 mg/m3 using a nose-only inhalation system. During the experimental period, we evaluated the clinical signs, body weight change, hematological and serum biochemical parameters, necropsy findings, organ weight, and histopathology findings. Additionally, we analyzed the bronchoalveolar lavage fluid (BALF), including differential leukocyte counts, and aluminum contents in the major organs and blood. Aluminum contents were the highest in lung tissues and showed a dose-dependent relationship in the exposure group. Histopathology showed alveolar macrophage accumulation in the lungs of rats in the 5 mg/m3 group during exposure and recovery. These changes tended to increase at the end of the recovery period. In the BALF analysis, total cell and neutrophil counts and lactate dehydrogenase, tumor necrosis factor-α, and interleukin-6 levels significantly increased in the 1 and 5 mg/m3 groups during exposure. Under the present experimental conditions, we suggested that the no-observed-adverse-effect level of Al2O3 NPs in male rats was 1 mg/m3, and the target organ was the lung.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Krewski, D., Yokel, R.A., Nieboer, E., Borchelt, D., Cohen, J., Harry, J., Kacew. S., Lindsay, J., Mahfouz, A.M. and Rondeau, V. (2007) Human health. risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J. Toxicol. Environ. Health B Crit. Rev., 10, 1–269.
U.S. Department of Health and Human Services Public Health Services Agency for Toxic Substances and Disease Registry (2009) Aluminum. pp. 34–35. Available from: http://www.Atsdr.cdc.gov/pdns/pdfs/pdn_doc_22.pdf/.
Li, X., Zhang, C., Zhang, X., Wang, S., Meng, Q., Wu, S., Yang, H., Xia, Y. and Chen, R. (2016) An acetyl-L-carnitine switch on mitochondrial dysfunction and rescue in the metabolomics study on aluminum oxide nanoparticles. Part. Fibre Toxicol., 13, 4.
Rai, A., Park, K., Zhou, L. and Zachariah, M.R. (2006) Understanding the mechanism of aluminium nanoparticle oxidation. Combust. Theor. Model., 10, 843–859.
Prakash, F.A, Babu, G.J.D., Lavanya, M., Vidhya, K.S. and Devasena, T. (2011) Toxicity studies of aluminium oxide nanoparticles in cell lines. Int. J. Nanotechnol. Appl., 5, 99–107.
Shirai, T., Watanabe, H., Fuji, M. and Takahashi, M. (2009) Structural properties and surfaces characteristics on aluminum oxide powders. Annual Report of the Ceramics Research Laboratory Nagoya Institute of Technology, 9, 23–31.
Kwon, J.T., Seo, G.B., Lee, M.M., Kim, H.M., Shim, I.S., Jo, E.H., Kim, P.J. and Choi, K.H. (2013) Pulmonary toxicity assessment of aluminum oxide nanoparticles via nasal instillation exposure. J. Environ. Health Sci., 39, 48–55.
Jederlinic, P.J., Abraham, J.L., Churg, A., Himmelstein, J.S., Epler, G.R. and Gaensier, E.A. (1990) Pulmonary fibrosis in aluminum oxide workers. Investigation of nine workers, with pathologic examination and microanalysis in three of them. Am. Rev. Respir Dis., 142, 1179–1184.
Raj, K.J.A. and Viswanathan, B. (2009) Effect of surface area, pore volume and particle size of P25 titania on the phase transformation of anatase to retile. Indian J. Chem., 48A, 1378–1382.
Shin, S.H., Lim, C.H., Kim, Y.S., Lee, Y.H., Kim, S.H. and Kim, J.C. (2017) Twenty-eight-day repeated inhalation toxicity study of nano-sized lanthanum oxide in male Sprague-Dawley rats. Environ. Toxicol., 32, 1226–1240.
Kim, Y.S., Lim, C.H., Shin, S.H. and Kim, J.C. (2017) Twenty-eight-day repeated inhalation toxicity study of nano-sized neodymium oxide in male Sprague-Dawley rats. Toxicol. Res., 33, 239–253.
OECD (2009) Guidelines for Testing of Chemicals. Test Guideline 412. Subacute Inhalation Toxicity: 28-Day Study. OECD, Paris.
Zhang, X., Xu, Y., Zhou, L., Zhang, C., Meng, Q., Wu, S., Wang, S., Ding, Z., Chen, X., Li, X. and Chen, R. (2015) sex-dependent depression-like behavior induced by respiratory administration of aluminum oxide nanoparticles. Int. J. Environ. Res. Public Health, 12, 15692–15705.
Pauluhn, J. (2009) Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxyhydroxides following 4-week inhalation exposure of rats: toxic effects are determined by agglomerated, not primary particle size. Toxicol. Sci., 109, 152–167.
Khan, I., Saeed, K. and Khan, I. (2017) Nanoparticles: properties, applications and toxicities. Arab. J. Chem. doi: 10.1016/j.arabjc.2017.05.011/.
ToxGuideTM for Aluminum. (2011) U.S. Department of Health and Human Services Public Health Service Agency for Toxic Substances and Disease Registry. Atlanta, GA.
Luo, Y.H., Chang, L.W. and Lin, P. 2015. Metal-based nanoparticles and the immune system: activation, inflammation, and potential applications. Biomed. Res. Int., 2015, 143720.
Khanna, P., Ong, C., Bay, B.H. and Baeg, G.H. (2015) Nano-toxicity: an interplay of oxidative stress, inflammation and cell death. Nanomaterials, 5, 1163–1180.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Kim, YS., Chung, YH., Seo, DS. et al. Twenty-Eight-Day Repeated Inhalation Toxicity Study of Aluminum Oxide Nanoparticles in Male Sprague-Dawley Rats. Toxicol Res. 34, 343–354 (2018). https://doi.org/10.5487/TR.2018.34.3.343
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.5487/TR.2018.34.3.343